HomeCompareATXMF vs MRK

ATXMF vs MRK: Dividend Comparison 2026

ATXMF yields 71428.57% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ATXMF wins by $1.6804617092236922e+25M in total portfolio value
10 years
ATXMF
ATXMF
● Live price
71428.57%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.6804617092236922e+25M
Annual income
$16,758,464,082,723,930,000,000,000,000,000.00
Full ATXMF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ATXMF vs MRK

📍 ATXMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodATXMFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ATXMF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ATXMF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATXMF
Annual income on $10K today (after 15% tax)
$6,071,428.57/yr
After 10yr DRIP, annual income (after tax)
$14,244,694,470,315,339,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ATXMF beats the other by $14,244,694,470,315,339,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATXMF + MRK for your $10,000?

ATXMF: 50%MRK: 50%
100% MRK50/50100% ATXMF
Portfolio after 10yr
$8.402308546118461e+24M
Annual income
$8,379,232,041,361,964,000,000,000,000,000.00/yr
Blended yield
99.73%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ATXMF
No analyst data
Altman Z
-8.4
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATXMF buys
0
MRK buys
0
No recent congressional trades found for ATXMF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricATXMFMRK
Forward yield71428.57%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1.6804617092236922e+25M$56.8K
Annual income after 10y$16,758,464,082,723,930,000,000,000,000,000.00$9,798.13
Total dividends collected$1.6801590475897682e+25M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ATXMF vs MRK ($10,000, DRIP)

YearATXMF PortfolioATXMF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$7,153,557$7,142,857.14$11,206$366.19+$7.14MATXMF
2$4,783,059,608$4,775,405,302.31$12,650$502.35+$4783.05MATXMF
3$2,989,196,089,253$2,984,078,215,471.53$14,407$694.19+$2989196.07MATXMF
4$1,746,108,740,720,723$1,742,910,300,905,223.00$16,585$967.82+$1746108740.70MATXMF
5$953,366,906,359,837,700$951,498,570,007,266,600.00$19,342$1,363.89+$953366906359.82MATXMF
6$486,546,837,026,708,500,000$485,526,734,436,903,500,000.00$22,913$1,947.19+$486546837026708.50MATXMF
7$232,096,820,383,666,640,000,000$231,576,215,268,048,070,000,000.00$27,662$2,823.89+$232096820383666624.00MATXMF
8$103,489,940,016,498,150,000,000,000$103,241,596,418,687,620,000,000,000.00$34,159$4,173.35+$103489940016498147328.00MATXMF
9$43,133,653,750,454,530,000,000,000,000$43,022,919,514,636,880,000,000,000,000.00$43,337$6,308.80+$4.313365375045453e+22MATXMF
10$16,804,617,092,236,920,000,000,000,000,000$16,758,464,082,723,930,000,000,000,000,000.00$56,776$9,798.13+$1.6804617092236922e+25MATXMF

ATXMF vs MRK: Complete Analysis 2026

ATXMFStock

Advantex Marketing International Inc. operates as an aggregator of independent merchants in Canada. The company operates through Merchant Cash Advance, Program, and Aeroplan Program segments. It also provides merchant cash advance (MCA) and loyalty marketing services to its community of merchants. The MCA meets working capital needs of merchants; and loyalty marketing provides merchants an economic way to market their establishments through its re-seller relationship with Aeroplan loyalty program. In addition, the company provides the Aeroplan program that allows members to earn aeroplan points on purchases at merchants. Further, the company's merchant partners operate in various business segments, including restaurants; independent inns, resorts, and selected hotels; spas; retailers of men's and ladies fashion, footwear, and accessories; florists and garden centers; health and beauty centers; gift stores; and home décor. Advantex Marketing International Inc. was incorporated in 1994 and is headquartered in Toronto, Canada.

Full ATXMF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ATXMF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATXMF vs SCHDATXMF vs JEPIATXMF vs OATXMF vs KOATXMF vs MAINATXMF vs JNJATXMF vs ABBVATXMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.